Oragenics, Inc. Completes Public Offering to Advance Neurology
![Oragenics, Inc. Completes Public Offering to Advance Neurology](https://investorshangout.com/images/blog/ihnews-Oragenics%2C%20Inc.%20Completes%20Public%20Offering%20to%20Advance%20Neurology.jpg)
Oragenics, Inc. Completes Public Offering
Oragenics, Inc. (NYSE American: OGEN), a pioneering biotechnology firm concentrated on developing innovative intranasal pharmaceuticals for neurological disorders, recently concluded its public offering. The offering involved 3,078,378 shares of common stock along with pre-funded warrants allowing for the purchase of an additional 5,028,206 shares of common stock. These shares were priced at $0.55 each, while the pre-funded warrants had a price of $0.549.
This successful offering has resulted in Oragenics having 8,659,071 shares of common stock outstanding along with pre-funded warrants for 5,028,206 shares. Importantly, the exercise price for these pre-funded warrants stands at just $0.001, facilitating an attractive opportunity for investors.
Significant Financial Outcomes
The gross proceeds from this public offering reached approximately $4.45 million, a sum that will be critical for Oragenics as it propels its research and development efforts forward. After deducting placement agent fees and estimated expenses associated with the offering, these funds are set to enhance the development of the company's ONP-002 product candidate alongside general working capital needs.
Placement and Legal Representation
Dawson James Securities, Inc. took the role of the sole placement agent for this offering. The company was ably represented by Shumaker, Loop & Kendrick, LLP throughout the offering process, while the placement agent was represented by ArentFox Schiff LLP based in Washington, DC.
Regulatory Framework
This transaction was executed under a registration statement on Form S-1 (File No. 333-281618), which included a base prospectus filed with the U.S. Securities and Exchange Commission (SEC). This statement was first filed on August 16, 2024, and was declared effective shortly before the offering closed on September 3, 2024.
About Oragenics, Inc.
Oragenics is currently navigating through the stages of biotechnology development, with a focus on nasal delivery systems tailored to treat neurological issues and combat infectious diseases. Their advancements specifically target mild traumatic brain injury, better known as concussion, and Niemann Pick Disease Type C. Furthermore, they are developing proprietary powder formulations and innovative intranasal delivery devices.
Contact Information
For further inquiries, contact: Janet Huffman, Chief Financial Officer
Phone: 813-286-7900
Email: jhuffman@oragenics.com
Investor Relations:
Rich Cockrell
Phone: 404.736.3838
Email: achv@cg.capital
Frequently Asked Questions
What is the purpose of Oragenics' recent public offering?
The recent offering aims to secure funding for the continued development of ONP-002 and to cover general corporate expenses and working capital.
Who served as the placement agent for Oragenics' offering?
Dawson James Securities, Inc. acted as the sole placement agent for the offering.
What is ONP-002?
ONP-002 is a product candidate developed by Oragenics aimed at treating neurological disorders through intranasal delivery.
What types of diseases is Oragenics focusing on?
Oragenics is primarily focused on treating neurological disorders, including mild traumatic brain injury and Niemann Pick Disease Type C.
Where can I find more information about Oragenics?
More information about Oragenics and its products can be found on their website at www.oragenics.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Investors Urged to Participate in Symbotic Class Action Lawsuit
- Investors Seek Leadership in Oddity Tech Fraud Case
- Perseus Mining Boosts Stake in Predictive Discovery to 19.9%
- Join the Class Action Against Super Micro Computer, Inc. Today
- Investigation into CrowdStrike Holdings Inc. by Faruqi & Faruqi
- Investigation into XPEL's Market Challenges and Legal Issues
- Investors Urged to Discuss Legal Strategy on Ford Losses
- Scannit Launches Innovative App to Empower Users Financially
- Red Pine Exploration Expands Private Placement to C$9.57 Million
- NeuroOne Medical to Showcase Innovations at Investor Conference
Recent Articles
- UK's Economic Growth Demands $1.3 Trillion Investment Strategy
- Investors Urged to Participate in Symbotic Class Action Lawsuit
- Investors Seek Leadership in Oddity Tech Fraud Case
- Baby Care Products Market Set for Significant Growth Ahead
- Perseus Mining Boosts Stake in Predictive Discovery to 19.9%
- Rand Logistics Welcomes New Leadership and Board Members
- Join the Class Action Against Super Micro Computer, Inc. Today
- Starwood Property Trust Secures Additional Shares for Growth
- US Urges Extension of UN Security Mission in Haiti
- AWAIM Launches Its Portfolio Solutions for Financial Advisors
- Faruqi & Faruqi Investigates Lifecore Biomedical Claims
- Investigation into CrowdStrike Holdings Inc. by Faruqi & Faruqi
- Investigation into XPEL's Market Challenges and Legal Issues
- Intel's Strategic Shift: Evaluating Mobileye's Future
- Investors Urged to Discuss Legal Strategy on Ford Losses
- Survey Shows Users Favor Unrestricted AI Interaction
- Empowerment Unleashed: WayMaker Men's Summit Ignites Growth
- Grupo Aeroportuario del Pacífico Secures Funding through Bond Issue
- Scannit Launches Innovative App to Empower Users Financially
- Red Pine Exploration Expands Private Placement to C$9.57 Million
- NeuroOne Medical to Showcase Innovations at Investor Conference
- Cognac Market Growth Driven by Health Trends and Innovation
- Industrial Automation Market Growth Fueled by AI Innovations
- Crypto Expert Foresees Bullish Bitcoin Trends Amid Economic Shifts
- EastGroup Properties Reports Strong Performance and Growth Plans
- Braze, Inc. Reports Impressive Q2 Earnings Performance
- Body-Worn Camera Market Set to Reach USD 27.65 Billion by 2033
- Sysco Corporation Expands Electric Vehicle Fleet in Canada
- GAP Successfully Issues Bond Certificates to Boost Growth
- Fortis Inc. Successfully Prices Major Unsecured Notes Offering
- Andretti Acquisition Corp II Launches $200 Million IPO
- Strategic Sale of Joe & Ross to GlacierPoint Enterprises Announced
- Projected Growth in Gas Separation Membrane Market by 2027
- Investors Targeted: Claims Investigation Against NANO Energy
- Investigating Investor Claims Against CAE: What You Need to Know
- Investigation of Symbotic: What Investors Need to Know
- Streamlined Benefits Integration for Better Member Experience
- Global Mechanical Seals Market Supplying Sustainable Solutions
- Innodyne Systems Forms Strategic Alliance with FCAH Aerospace
- Market Trends: Investors Brace for Economic Climaxes Ahead
- Broadcom's Revenue Forecast Raises Concerns Amidst Growth
- Unveiling the Incredible Growth of Quanta Services Stock
- Transform Your Investment: The Rise of SPS Commerce Stocks
- Awaysis Capital Enhances Transparency with Re-Audited Finances
- Awaysis Capital's Commitment to Transparency and Growth
- Investigation into Extreme Networks: A Call to Action for Investors
- GorgeousTV Launches Innovative Shopping App for Streamers
- Faruqi & Faruqi Investigates Concerns for Sprinklr Investors
- Investigation into MacroGenics Sparks Investor Interest and Options
- Future Growth of the Global Steam Traps Market